Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Session VII: Immune Checkpoint Inhibitors for NSCLC
Debate: Adjuvant vs Neoadjuvant CPIs in Resectable NSCLC? - Neoadjuvant
Thursday, August 25, 2022
2:20 PM – 2:27 PM
Debate Speaker(s)
Jamie E. Chaft, MD
Memorial Sloan Kettering Cancer Center
